首页> 外文期刊>Acta medica Iranica. >INTRAVENOUS REGIONAL BLOCK WITH PHENTOLAMINE IN THE TREATMENT OF COMPLEX REGIONAL PAIN SYNDROME
【24h】

INTRAVENOUS REGIONAL BLOCK WITH PHENTOLAMINE IN THE TREATMENT OF COMPLEX REGIONAL PAIN SYNDROME

机译:芬太尼静脉区域阻滞治疗复杂性区域疼痛综合征。

获取原文
           

摘要

Complex regional pain syndrome (CRPS) is a variety of painful conditions following injury which appears regionally having a distal predominance of abnormal findings. This study, evaluate the use of phentolamine for sympathetic block and regional anesthesia in treatment of CRPS related pain. In this study, 68 patients with CRPS who were referred to pain clinics of Imam Hossein and Akhtar Hospitals and Gandy Center of Surgery between 2003-2008 were evaluated. Forty three of 87 patients finally undertaken intravenous regional sympatholytic block according to therapeutic protocol. 37 patients (86%) received one block, 2 of them (4.75%) received 2 repetitions of blocks and finally repeated block for three times occurred in 4 patients (9.3%). A week after block pain relief outcomes was recorded as following; excellent in 7 patients (16.3%), good in the 32 patients (74.4%) and moderate in the 4 patients (9.3%). After a month, 8 patients (18.5%) showed excellent relief and it was good and moderate in 32 (78%) and one case (2.4%), respectively. Pain relief after three months was excellent, good and moderate in the 13 patients (31.7%), 25 patients (61%) and 3 patients (7.3%), respectively. In this study level of pain relief was significant in various intervals and it showed significant difference in relief three months after block (P=0.04). CRPS due to SMP (sympathetically maintained pain) is thought to be alleviated by phentolamine. Intravenous phentolamine infusion is potentially a new significant option for the therapy of CRPS.
机译:复杂区域性疼痛综合征(CRPS)是受伤后出现的多种痛苦状况,在局部看来以远端异常为主。本研究评估了酚妥拉明在交感神经阻滞和区域麻醉中治疗CRPS相关疼痛的用途。在这项研究中,评估了2003年至2008年之间转诊至Imam Hossein和Akhtar医院及Gandy外科中心的疼痛诊所的68例CRPS患者。根据治疗方案,87名患者中的43名最终接受了静脉区域性交感神经阻滞。 37例患者(86%)接受了1次阻断治疗,其中2例(4.75%)接受了2次重复阻断治疗,最后4例患者(9.3%)进行了3次重复阻断治疗。阻滞止痛一周后记录如下:优7例(16.3%),良32例(74.4%),中4例(9.3%)。一个月后,有32例(78%)和1例(2.4%)的8例患者(18.5%)表现出良好的缓解,良好和中度。三个月后的疼痛缓解分别为13例(31.7%),25例(61%)和3例(7.3%)良好,良好和中度。在这项研究中,疼痛缓解的水平在不同的时间间隔内均显着,并且在阻滞后三个月显示出明显的缓解(P = 0.04)。酚妥拉明可缓解因SMP(交感神经维持性疼痛)引起的CRPS。静脉注射酚妥拉明可能是治疗CRPS的新的重要选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号